Swiss Biotech Insight Series 2019

Share this event

Clinical Trial Strategy:  Fine-tuning the Risk–Reward Profile


The event, organized by the Swiss Biotech Association in association with Parexel Switzerland, will take place on Thursday 19 September 2019 in Lausanne.


Preliminary Programme

1PM – Registration and networking (refreshments will be provided)


1:45PM – Session 1: The fast lane to proof of concept
  1. The Fast Lane to Proof of Concept
  2. From No to Yes: What are licensing partners looking for?
  3. Clinical development strategies: lessons learnt and implications for the future
  4. New frontiers in Pharma R&D investment – Sharing risks and rewards over product development Cycle
  5. Clinical data and stock market inflection points 


3:15PM – Break


4PM – Session 2: New technologies and risk management approaches
  1. Adaptive Designs: Statistical, Operational and Regulatory Issues
  2. Using Biomarkers to Improve the Quality of Decision Making in Drug Development
  3. Real World Data Science and the future of Clinical trial design
  4. Panel Discussion on the China Opportunity: Considerations for Clinical Strategy


5:30 – Cocktail



More information and registration